Logo image of CS.PA

AXA SA (CS.PA) Stock Fundamental Analysis

EPA:CS - Euronext Paris - Matif - FR0000120628 - Common Stock - Currency: EUR

38.76  +0.11 (+0.28%)

Fundamental Rating

5

CS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS has a decent growth rate and is not valued too expensively. Finally CS also has an excellent dividend rating. With these ratings, CS could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CS had positive earnings in the past year.
In the past year CS had a positive cash flow from operations.
In the past 5 years CS has always been profitable.
In the past 5 years CS always reported a positive cash flow from operatings.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

1.2 Ratios

CS has a Return On Assets of 1.12%. This is comparable to the rest of the industry: CS outperforms 58.33% of its industry peers.
CS's Return On Equity of 15.16% is fine compared to the rest of the industry. CS outperforms 66.67% of its industry peers.
CS has a Return On Invested Capital (1.32%) which is comparable to the rest of the industry.
CS had an Average Return On Invested Capital over the past 3 years of 1.23%. This is in line with the industry average of 2.02%.
The 3 year average ROIC (1.23%) for CS is below the current ROIC(1.32%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.12%
ROE 15.16%
ROIC 1.32%
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10

1.3 Margins

CS has a Profit Margin of 8.20%. This is comparable to the rest of the industry: CS outperforms 44.44% of its industry peers.
In the last couple of years the Profit Margin of CS has grown nicely.
CS has a Operating Margin of 11.69%. This is comparable to the rest of the industry: CS outperforms 58.33% of its industry peers.
CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.69%
PM (TTM) 8.2%
GM N/A
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

5

2. Health

2.1 Basic Checks

CS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CS has less shares outstanding
CS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CS has about the same debt to assets ratio.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200B 400B 600B 800B

2.2 Solvency

CS has an Altman-Z score of 0.35. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.35, CS belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
CS has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as CS would need 3.32 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.32, CS is in line with its industry, outperforming 58.33% of the companies in the same industry.
CS has a Debt/Equity ratio of 0.57. This is a neutral value indicating CS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.57, CS is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 3.32
Altman-Z 0.35
ROIC/WACC0.13
WACC10.32%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B

2.3 Liquidity

CS has a Current Ratio of 1.00. This is a normal value and indicates that CS is financially healthy and should not expect problems in meeting its short term obligations.
CS has a better Current ratio (1.00) than 83.33% of its industry peers.
CS has a Quick Ratio of 1.00. This is a normal value and indicates that CS is financially healthy and should not expect problems in meeting its short term obligations.
CS's Quick ratio of 1.00 is amongst the best of the industry. CS outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

4

3. Growth

3.1 Past

CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.49%, which is quite good.
CS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.03% yearly.
The Revenue for CS has decreased by -11.35% in the past year. This is quite bad
Measured over the past years, CS shows a decrease in Revenue. The Revenue has been decreasing by -4.60% on average per year.
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%

3.2 Future

CS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.80% yearly.
Based on estimates for the next years, CS will show a small growth in Revenue. The Revenue will grow by 5.65% on average per year.
EPS Next Y7.01%
EPS Next 2Y8.89%
EPS Next 3Y8.1%
EPS Next 5Y5.8%
Revenue Next Year-9.57%
Revenue Next 2Y-2.36%
Revenue Next 3Y-0.04%
Revenue Next 5Y5.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.00, the valuation of CS can be described as correct.
63.89% of the companies in the same industry are more expensive than CS, based on the Price/Earnings ratio.
CS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
The Price/Forward Earnings ratio is 9.62, which indicates a very decent valuation of CS.
63.89% of the companies in the same industry are more expensive than CS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12
Fwd PE 9.62
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CS is valued a bit cheaper than 63.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.62
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.71
PEG (5Y)0.37
EPS Next 2Y8.89%
EPS Next 3Y8.1%

7

5. Dividend

5.1 Amount

CS has a Yearly Dividend Yield of 5.56%, which is a nice return.
Compared to an average industry Dividend Yield of 4.63, CS pays a bit more dividend than its industry peers.
CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 5.56%

5.2 History

The dividend of CS has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CS pays out 62.10% of its income as dividend. This is not a sustainable payout ratio.
CS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.1%
EPS Next 2Y8.89%
EPS Next 3Y8.1%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (3/7/2025, 7:00:00 PM)

38.76

+0.11 (+0.28%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)07-31 2025-07-31
Inst Owners36.79%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap85.85B
Analysts80
Price Target41.3 (6.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.56%
Yearly Dividend1.76
Dividend Growth(5Y)4.19%
DP62.1%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.1%
PT rev (3m)2.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.18%
EPS NY rev (3m)-1.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.65%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE 12
Fwd PE 9.62
P/S 0.98
P/FCF 10.62
P/OCF 10.03
P/B 1.81
P/tB 3.5
EV/EBITDA N/A
EPS(TTM)3.23
EY8.33%
EPS(NY)4.03
Fwd EY10.39%
FCF(TTM)3.65
FCFY9.41%
OCF(TTM)3.86
OCFY9.97%
SpS39.5
BVpS21.37
TBVpS11.07
PEG (NY)1.71
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 15.16%
ROCE 1.63%
ROIC 1.32%
ROICexc 1.37%
ROICexgc 1.79%
OM 11.69%
PM (TTM) 8.2%
GM N/A
FCFM 9.24%
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
ROICexc(3y)1.28%
ROICexc(5y)1.05%
ROICexgc(3y)1.64%
ROICexgc(5y)1.33%
ROCE(3y)1.52%
ROCE(5y)1.25%
ROICexcg growth 3Y24.63%
ROICexcg growth 5Y6.98%
ROICexc growth 3Y21.16%
ROICexc growth 5Y7.2%
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 3.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.55%
Interest Coverage 1.51
Cash Conversion N/A
Profit Quality 112.61%
Current Ratio 1
Quick Ratio 1
Altman-Z 0.35
F-Score7
WACC10.32%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.36%
Profit Quality(3y)112.32%
Profit Quality(5y)257.76%
High Growth Momentum
Growth
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
EPS Next Y7.01%
EPS Next 2Y8.89%
EPS Next 3Y8.1%
EPS Next 5Y5.8%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
Revenue Next Year-9.57%
Revenue Next 2Y-2.36%
Revenue Next 3Y-0.04%
Revenue Next 5Y5.65%
EBIT growth 1Y4.29%
EBIT growth 3Y12.44%
EBIT growth 5Y-0.05%
EBIT Next Year23.05%
EBIT Next 3Y8.68%
EBIT Next 5YN/A
FCF growth 1Y9.42%
FCF growth 3Y-33.47%
FCF growth 5Y-1.8%
OCF growth 1Y11.23%
OCF growth 3Y-32.45%
OCF growth 5Y-1.79%